Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects

NCT04464733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: HRS9950
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.